DK3341725T3 - Fremgangsmåder til detektering af phosphoryleret alpha-synuklein - Google Patents
Fremgangsmåder til detektering af phosphoryleret alpha-synuklein Download PDFInfo
- Publication number
- DK3341725T3 DK3341725T3 DK16766088.5T DK16766088T DK3341725T3 DK 3341725 T3 DK3341725 T3 DK 3341725T3 DK 16766088 T DK16766088 T DK 16766088T DK 3341725 T3 DK3341725 T3 DK 3341725T3
- Authority
- DK
- Denmark
- Prior art keywords
- methods
- alpha synuclein
- phosphorylated alpha
- detecting phosphorylated
- detecting
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562209800P | 2015-08-25 | 2015-08-25 | |
| US201662297777P | 2016-02-19 | 2016-02-19 | |
| PCT/IB2016/055088 WO2017033152A1 (en) | 2015-08-25 | 2016-08-25 | Methods for detecting phosphorylated alpha-synuclein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3341725T3 true DK3341725T3 (da) | 2021-09-06 |
Family
ID=56926235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16766088.5T DK3341725T3 (da) | 2015-08-25 | 2016-08-25 | Fremgangsmåder til detektering af phosphoryleret alpha-synuklein |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US10852309B2 (da) |
| EP (1) | EP3341725B1 (da) |
| JP (2) | JP6989927B2 (da) |
| CA (1) | CA2994518A1 (da) |
| DK (1) | DK3341725T3 (da) |
| ES (1) | ES2890073T3 (da) |
| HK (1) | HK1257103A1 (da) |
| HU (1) | HUE056054T2 (da) |
| PT (1) | PT3341725T (da) |
| WO (1) | WO2017033152A1 (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017033152A1 (en) * | 2015-08-25 | 2017-03-02 | Prothena Biosciences Limited | Methods for detecting phosphorylated alpha-synuclein |
| EP3548074A4 (en) | 2016-12-02 | 2020-07-01 | Prothena Biosciences Limited | INFRARED ASSAY DETECTING SECONDARY ALPHA-SYNUCLEIN STRUCTURE PROFILES |
| EP3555127A1 (en) | 2016-12-16 | 2019-10-23 | H. Lundbeck A/S | Agents, uses and methods |
| BR112019016374A2 (pt) | 2017-02-17 | 2020-04-07 | Bristol-Myers Squibb Company | anticorpos para alfa-sinucleína e usos dos mesmos |
| GB201720975D0 (en) | 2017-12-15 | 2018-01-31 | Ucb Biopharma Sprl | Anti-alpha synuclein antibodies |
| GB201720970D0 (en) | 2017-12-15 | 2018-01-31 | Ucb Biopharma Sprl | Antibodies |
| CN111630382A (zh) * | 2017-12-21 | 2020-09-04 | H.隆德贝克有限公司 | α-共核蛋白病的测定、方法和治疗 |
| GB201803553D0 (en) | 2018-03-06 | 2018-04-18 | Univ Newcastle | Detection of pathological protein aggregation |
| WO2020146497A1 (en) * | 2019-01-09 | 2020-07-16 | The Regents Of The University Of California | An electrochemiluminescence elisa for ps129-a-synuclein |
| CN112710850A (zh) * | 2020-12-29 | 2021-04-27 | 苏州百志生物科技有限公司 | 一种检测人体液中α-突触核蛋白含量的试剂盒 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US4486530A (en) | 1980-08-04 | 1984-12-04 | Hybritech Incorporated | Immunometric assays using monoclonal antibodies |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| EP0832981A1 (en) | 1987-02-17 | 1998-04-01 | Pharming B.V. | DNA sequences to target proteins to the mammary gland for efficient secretion |
| US5633076A (en) | 1989-12-01 | 1997-05-27 | Pharming Bv | Method of producing a transgenic bovine or transgenic bovine embryo |
| CA2084307A1 (en) | 1990-06-01 | 1991-12-02 | Cetus Oncology Corporation | Compositions and methods for identifying biologically active molecules |
| DK0590058T3 (da) | 1991-06-14 | 2004-03-29 | Genentech Inc | Humaniseret heregulin-antistof |
| DE667959T1 (de) * | 1992-10-26 | 2000-04-20 | Dale B Schenk | VERFAHREN UND ZUSAMMENSETZUNGEN FÜR DEN NACHWEIS VON LÖSLICHEM-g(b)-AMYLOIDPEPTID. |
| US5914241A (en) | 1993-01-19 | 1999-06-22 | Biosite Diagnostics, Inc. | Assays and kits for detecting analytes in the presence of cross-reacting substances |
| US5827690A (en) | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
| US5965375A (en) | 1997-04-04 | 1999-10-12 | Biosite Diagnostics | Diagnostic tests and kits for Clostridium difficile |
| US8506959B2 (en) | 2002-11-01 | 2013-08-13 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
| US20080014194A1 (en) * | 2003-10-31 | 2008-01-17 | Elan Pharmaceuticals, Inc. | Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease |
| US7674599B2 (en) * | 2003-11-08 | 2010-03-09 | Elan Pharmaceuticals, Inc. | Methods of using antibodies to detect alpha-synuclein in fluid samples |
| US7572640B2 (en) | 2004-09-28 | 2009-08-11 | Singulex, Inc. | Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties |
| EP2185592B1 (en) * | 2007-09-13 | 2013-01-23 | University Of Zurich Prorektorat Forschung | Monoclonal amyloid beta (abeta)-specific antibody and uses thereof |
| DK2732289T3 (da) * | 2011-07-13 | 2018-05-22 | Acumen Pharmaceuticals Inc | Antistoffer, kit og in vitro-fremgangsmåde til påvisning af beta-amyloid-oligomerer |
| WO2017033152A1 (en) | 2015-08-25 | 2017-03-02 | Prothena Biosciences Limited | Methods for detecting phosphorylated alpha-synuclein |
-
2016
- 2016-08-25 WO PCT/IB2016/055088 patent/WO2017033152A1/en active Application Filing
- 2016-08-25 PT PT167660885T patent/PT3341725T/pt unknown
- 2016-08-25 EP EP16766088.5A patent/EP3341725B1/en active Active
- 2016-08-25 ES ES16766088T patent/ES2890073T3/es active Active
- 2016-08-25 CA CA2994518A patent/CA2994518A1/en active Pending
- 2016-08-25 HU HUE16766088A patent/HUE056054T2/hu unknown
- 2016-08-25 DK DK16766088.5T patent/DK3341725T3/da active
- 2016-08-25 US US15/247,598 patent/US10852309B2/en active Active
- 2016-08-25 JP JP2018510519A patent/JP6989927B2/ja active Active
-
2018
- 2018-12-20 HK HK18116355.5A patent/HK1257103A1/zh unknown
-
2020
- 2020-10-30 US US17/086,158 patent/US20210165000A1/en not_active Abandoned
-
2021
- 2021-07-28 JP JP2021122883A patent/JP7244949B2/ja active Active
-
2023
- 2023-01-26 US US18/160,270 patent/US20230228772A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP7244949B2 (ja) | 2023-03-23 |
| JP2018526642A (ja) | 2018-09-13 |
| ES2890073T3 (es) | 2022-01-17 |
| JP2021193374A (ja) | 2021-12-23 |
| JP6989927B2 (ja) | 2022-02-03 |
| WO2017033152A1 (en) | 2017-03-02 |
| HK1257103A1 (zh) | 2019-10-11 |
| US10852309B2 (en) | 2020-12-01 |
| EP3341725B1 (en) | 2021-08-18 |
| PT3341725T (pt) | 2021-09-21 |
| US20170192017A1 (en) | 2017-07-06 |
| HUE056054T2 (hu) | 2022-02-28 |
| US20210165000A1 (en) | 2021-06-03 |
| US20230228772A1 (en) | 2023-07-20 |
| EP3341725A1 (en) | 2018-07-04 |
| CA2994518A1 (en) | 2017-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3497207T3 (da) | Fremgangsmåder til påvisning af aav | |
| DK3341725T3 (da) | Fremgangsmåder til detektering af phosphoryleret alpha-synuklein | |
| DK3294700T3 (da) | Fremgangsmåde til fremstilling af limonen-4-ol | |
| DK3072835T3 (da) | Fremgangsmåde til fremføring | |
| DK3473783T3 (da) | Fremgangsmåde til fremstilling af gulvplader | |
| DK3374748T3 (da) | Fremgangsmåde til udarbejdelse af et prøveforsøg | |
| DK3198035T3 (da) | Fremgangsmåder til forudsigelse af medicinrespons | |
| DK2972353T3 (da) | Forbedrede fremgangsmåder til udførelse af multipleksanalyser | |
| DK3344805T3 (da) | Fremgangsmåde til udvælgelse af aptamerer til ubundne mål | |
| DK3314010T3 (da) | Fremgangsmåde til detektering af kromosomaberrationer | |
| DK3298718T3 (da) | Teknikker til signal-forlængelsessignalering | |
| DK3384274T3 (da) | Fremgangsmåder til prøvekarakterisering | |
| DK3122444T3 (da) | Fremgangsmåde til fremstilling af membraner | |
| DK3126373T3 (da) | Fremgangsmåde til fremstilling af amg 416 | |
| DK3274469T3 (da) | Fremgangsmåder til detektering af en biologisk kontaminant | |
| DK3359281T3 (da) | Fremgangsmåde til udtrækning af CO2 | |
| DK3519094T3 (da) | System til forberedelse af en prøve | |
| DK3529233T3 (da) | Fremgangsmåde til fremstilling af 3-alkylsulfanyl-2-chlor-n-(1-alkyl-1h-tetrazol-5-yl)-4-trifluoromethyl-benzamider | |
| DK3206586T3 (da) | Fremgangsmåde til detektion af dikrotisk hak | |
| DK3365436T3 (da) | Fremgangsmåder til fremstilling af en primær celleprøve | |
| DK3340796T3 (da) | Sonder til afbildning af huntingtin-protein | |
| DK3152332T3 (da) | Fremgangsmåde til at analysere methylering | |
| DK3384045T3 (da) | Fremgangsmåde til bestemmelse af celleklonalitet | |
| DK3274143T3 (da) | Fremgangsmåde til fremstilling af lignocellulosematerialer | |
| DK3367910T3 (da) | Fremgangsmåde til anvendelse af en sondeafdækning |